ABSTRACT
Objectives This study aimed to investigate a novel semi-automated three-dimensional (3D) quantification of the pericoronary epicardial adipose tissue radiodensity (PCATrd).
Methods Twenty-four subjects who previously underwent contrast-enhanced cardiac CT scans were retrospectively identified. The PCATrd was measured in ITK-SNAP imaging software using a Hounsfield unit threshold (−190,-3) to define epicardial adipose tissue (EAT). A spherical 3D brush tool was used on multiplanar reformatted images to segment the PCAT. We defined the PCATrd as EAT within the orthogonal distance from the coronary artery (CA) outer wall equal to the diameter of the corresponding CA segment. The segmentation followed the path of major CAs. Additionally, the PCAT of twenty-five calcified segments were segmented. Reliability of this novel segmentation protocol was assessed using Dice Similarity Coefficients (DSCs) and intraclass coefficient (ICC).
Results The segmentation reproducibility for the PCAT was high, with intraobserver DSC 0.86±0.04 for the full length of major CAs and 0.85±0.07 for the calcified segments, and interobserver DSC 0.84±0.04 for the full length of major CAs and 0.83±0.05 for the calcified segments. The reproducibility of the PCATrd value assessed by ICC was also excellent, with intraobserver ICC 0.99 for the full length of major CAs and 0.99 for the calcified segments, and interobserver ICC 0.99 for the full length of major CAs and 0.99 for the calcified segments.
Conclusions Our novel 3D PCATrd quantification technique is reliable and reproducible. The availability of the open source software and detailed image analysis pipeline will enable reliable replications and broad uptake of our technique.
Key points
We have produced a novel, semiautomated technique to comprehensively quantify pericoronary epicardial adipose tissue radiodensity (PCATrd) which is a novel imaging biomarker of coronary inflammation.
Our method of PCAT segmentation has excellent reproducibility.
We use open source software and provide detailed image analysis pipeline of quantifying PCATrd, which will allow easy replication and broad uptake of our technique.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This is a retrospective study identified from a local clinical database.
Funding Statement
The authors state that this work has not received any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health Research Ethics Board at the University of Alberta
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data can be available upon reseasonal requests.
Abbreviations
- (PCATrd)
- pericoronary epicardial adipose tissue radiodensity
- (EAT)
- epicardial adipose tissue
- (3D)
- three-dimensional
- (DSCs)
- Dice Similarity Coefficients
- (ICC)
- intraclass coefficient
- (CA)
- coronary artery
- (CCTA)
- coronary computed tomography angiography
- (LM)
- left main
- (LAD)
- left anterior descending
- (LCX)
- left circumflex
- (RCA)
- arteries right coronary artery
